Mirion to Host Investor Day on December 3, 2024

Rhea-AI Summary

Mirion Technologies (NYSE: MIR) has announced its upcoming Investor Day scheduled for December 3, 2024, at 2:00 p.m. ET at the New York Stock Exchange. The event will feature presentations from key leadership, including CEO Thomas Logan on radiation safety strategy, CFO Brian Schopfer on financial outlook, Technologies Group President Loic Eloy on nuclear innovations, and Medical Group EVP Luis Rivera on cancer care developments.

The event will be webcast live, with in-person attendance to invited institutional investors and financial analysts who must register by November 18, 2024. Interested parties can access the webcast through the company's IR website or via a dedicated registration link.

ATLANTA--(BUSINESS WIRE)-- Mirion (NYSE: MIR), a leading provider of radiation safety solutions supporting advancements in nuclear power and cancer care, today announced that it will host an Investor Day on Tuesday, December 3, 2024, beginning at 2:00 p.m. ET. The event will be held at the New York Stock Exchange and webcast live.

Due to limited capacity, in-person attendance is by invitation only. Institutional investors and financial analysts wishing to attend in-person should contact ir@mirion.com before in-person registration closes on Monday, November 18, 2024. Interested parties can register for the live webcast at https://mirion-investor-day.open-exchange.net/. A link to the live webcast will also be available on the Mirion Investor Relations website at ir.mirion.com.

The event will feature presentations by members of Mirion’s leadership team, including:

• Thomas Logan, CEO, discussing the Company’s strategy and growth through radiation safety expertise;
• Brian Schopfer, CFO, sharing Mirion’s financial outlook and value creation strategy;
• Loic Eloy, President of the Technologies Group, presenting an overview of the Technologies Group and its innovations supporting the nuclear renaissance;
• Luis Rivera, EVP of the Medical Group, highlighting the Medical Group’s role in the growth of cancer care.

Formal presentations will be followed by a question-and-answer session.

To stay up to date on the latest information, visit the Mirion investor website at ir.mirion.com.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at mirion.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241024617980/en/

For investor inquiries:

Eric Linn

ir@mirion.com

For media inquiries:

Erin Schesny

media@mirion.com

Source: Mirion

FAQ

When is Mirion's (MIR) 2024 Investor Day?

Mirion's Investor Day is scheduled for Tuesday, December 3, 2024, beginning at 2:00 p.m. ET at the New York Stock Exchange.

How can I attend Mirion's (MIR) 2024 Investor Day virtually?

You can register for the live webcast at https://mirion-investor-day.open-exchange.net/ or access it through Mirion's Investor Relations website at ir.mirion.com.

What topics will be covered at Mirion's (MIR) 2024 Investor Day?

The event will cover Mirion's strategy in radiation safety, financial outlook, Technologies Group innovations in nuclear renaissance, and Medical Group's role in cancer care growth.

What is the registration deadline for in-person attendance at Mirion's (MIR) Investor Day?

In-person registration for institutional investors and financial analysts closes on Monday, November 18, 2024.